| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.072 | 0.2 |